Flagship Harbor Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.1M | Buy |
6,184
+449
| +8% | +$216K | 0.12% | 165 |
|
|
2026
Q1 | $2.82M | Sell |
5,735
-15
| -0.3% | -$8.14K | 0.12% | 160 |
|
|
2025
Q4 | $3.33M | Sell |
5,750
-434
| -7% | -$245K | 0.16% | 137 |
|
|
2025
Q3 | $3M | Sell |
6,184
-586
| -9% | -$273K | 0.13% | 150 |
|
|
2025
Q2 | $2.75M | Buy |
6,770
+1,807
| +36% | +$756K | 0.13% | 157 |
|
|
2025
Q1 | $2.47M | Sell |
4,963
-201
| -4% | -$109K | 0.13% | 147 |
|
|
2024
Q4 | $2.69M | Sell |
5,164
-567
| -10% | -$312K | 0.14% | 132 |
|
|
2024
Q3 | $3.55M | Buy |
5,731
+3
| +0.1% | +$1.78K | 0.19% | 116 |
|
|
2024
Q2 | $3.17M | Sell |
5,728
-23
| -0.4% | -$13.2K | 0.19% | 116 |
|
|
2024
Q1 | $3.34M | Sell |
5,751
-123
| -2% | -$69K | 0.21% | 106 |
|
|
2023
Q4 | $3.12M | Sell |
5,874
-23
| -0.4% | -$11.1K | 0.23% | 101 |
|
|
2023
Q3 | $2.99M | Sell |
5,897
-93
| -2% | -$49.6K | 0.25% | 93 |
|
|
2023
Q2 | $3.13M | Sell |
5,990
-253
| -4% | -$137K | 0.26% | 93 |
|
|
2023
Q1 | $3.6M | Buy |
6,243
+59
| +1% | +$33.3K | 0.34% | 72 |
|
|
2022
Q4 | $3.41M | Sell |
6,184
-75
| -1% | -$39.7K | 0.35% | 72 |
|
|
2022
Q3 | $3.17M | Sell |
6,259
-24
| -0.4% | -$13.4K | 0.37% | 66 |
|
|
2022
Q2 | $3.41M | Sell |
6,283
-222
| -3% | -$122K | 0.38% | 60 |
|
|
2022
Q1 | $3.84M | Sell |
6,505
-325
| -5% | -$187K | 0.37% | 59 |
|
|
2021
Q4 | $4.56M | Buy |
6,830
+127
| +2% | +$79.3K | 0.43% | 53 |
|
|
2021
Q3 | $3.38M | Hold |
6,703
| – | – | 0.36% | 66 |
|
|
2021
Q2 | $3.38M | Buy |
6,703
+423
| +7% | +$200K | 0.36% | 66 |
|
|
2021
Q1 | $2.87M | Buy |
6,280
+102
| +2% | +$48.7K | 0.33% | 72 |
|
|
2020
Q4 | $2.88M | Buy |
6,178
+442
| +8% | +$207K | 0.36% | 66 |
|
|
2020
Q3 | $2.53M | Buy |
5,736
+271
| +5% | +$112K | 0.34% | 60 |
|
|
2020
Q2 | $1.98M | Sell |
5,465
-88
| -2% | -$29.5K | 0.29% | 70 |
|
|
2020
Q1 | $1.57M | Buy |
5,553
+965
| +21% | +$304K | 0.32% | 68 |
|
|
2019
Q4 | $1.49M | Buy |
4,588
+1
| +0% | +$303 | 0.26% | 87 |
|
|
2019
Q3 | $1.34M | Buy |
4,587
+66
| +1% | +$18.9K | 0.26% | 87 |
|
|
2019
Q2 | $1.33M | Sell |
4,521
-122
| -3% | -$33.6K | 0.28% | 86 |
|
|
2019
Q1 | $1.27M | Sell |
4,643
-79
| -2% | -$19.7K | 0.26% | 92 |
|
|
2018
Q4 | $1.06M | Sell |
4,722
-608
| -11% | -$143K | 0.26% | 92 |
|
|
2018
Q3 | $1.32M | Sell |
5,330
-3
| -0.1% | -$690 | 0.25% | 103 |
|
|
2018
Q2 | $1.1M | Buy |
5,333
+722
| +16% | +$153K | 0.22% | 111 |
|
|
2018
Q1 | $934K | Sell |
4,611
-139
| -3% | -$29.2K | 0.28% | 103 |
|
|
2017
Q4 | $957K | Buy |
4,750
+18
| +0.4% | +$3.45K | 0.28% | 99 |
|
|
2017
Q3 | $911K | Buy |
4,732
+13
| +0.3% | +$2.35K | 0.3% | 95 |
|
|
2017
Q2 | $841K | Sell |
4,719
-31
| -0.7% | -$5.21K | 0.29% | 97 |
|
|
2017
Q1 | $725K | Buy |
4,750
+930
| +24% | +$142K | 0.28% | 109 |
|
|
2016
Q4 | $549K | Buy |
+3,820
| New | +$563K | 0.24% | 123 |
|
Other funds holding TMO
Flagship Harbor Advisors's TMO Position: Q2 2026 in Review
Flagship Harbor Advisors increased its Thermo Fisher Scientific (TMO) stake by 7.8% in Q2 2026, buying an estimated $216K and bringing the position to 6,184 shares worth $3.1M. The position accounts for 0.12% of the portfolio, ranked #165.
Flagship Harbor Advisors first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.56M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Flagship Harbor Advisors held 6,184 shares of Thermo Fisher Scientific worth $3.1M as of Q2 2026.
- Flagship Harbor Advisors bought 449 Thermo Fisher Scientific shares in Q2 2026, an estimated $216K.
- Thermo Fisher Scientific made up 0.12% of Flagship Harbor Advisors's portfolio in Q2 2026, its #165 holding.
- Flagship Harbor Advisors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
- Flagship Harbor Advisors's Thermo Fisher Scientific position peaked at $4.56M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.